A Comparison of the Effects of Empagliflozin and Sitagliptin, When Combined With Metformin, on Lipid Levels in Patients with Type 2 Diabetes: A Clinical Investigation.

Ahmed, Mazhar; Saeed, Asjad; Khan, Muhammad Zarar; Javaid, Sana Z; Aslam, Farhan; Dar, Savida Ilyas

Ahmed, Mazhar; Saeed, Asjad; Khan, Muhammad Zarar; Javaid, Sana Z; Aslam, Farhan; Dar, Savida Ilyas.

Afiliação

Ahmed M; Internal Medicine, Federal Government Polyclinic Hospital, Islamabad, PAK.
Saeed A; Internal Medicine, Federal Government Polyclinic Hospital, Islamabad, PAK.
Khan MZ; Internal Medicine, Federal Government Polyclinic Hospital, Islamabad, PAK.
Javaid SZ; Internal Medicine, Shifa College of Medicine, Shifa International Hospital, Islamabad, PAK.
Aslam F; Internal Medicine, Federal Government Polyclinic Hospital, Islamabad, PAK.
Dar SI; Internal Medicine, Federal Government Polyclinic Hospital, Islamabad, PAK.

Cureus ; 15(9): e44709, 2023 Sep.

Article em En | MEDLINE | ID: mdl-37809225

Palavras-chave

diabetes mellitus; empagliflozin; lipid profile; metformin; sitagliptin

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Cureus Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google